Cite
APA Citation
Trivedi, N. D., Armstrong, S., Wang, H., Hartley, M., Deeken, J., Ruth He, A., Subramaniam, D., Melville, H., Albanese, C., Marshall, J. L., Hwang, J., & Pishvaian, M. J. (2021). a phase I trial of the mTOR inhibitor temsirolimus in combination with capecitabine in patients with advanced malignancies. Cancer medicine, 10, 1944–1954. http://access.bl.uk/ark:/81055/vdc_100123980491.0x000017